---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-044078"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2026-09-24T12:30:16+00:00"
generated_at: "2026-09-24T13:02:52.891570+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics prices $1.5M private placement of units with warrants

## Summary
- 903,614 units at $1.6599/unit; each includes pre-funded warrant (exercise $0.0001) and right to common warrant (exercise $1.66, 5.5-yr) subject to stockholder approval.
- Gross proceeds ~$1.5M; net for clinical trial HCW9302, IND-enabling for HCW11-018b and HCW11-040, and general corporate purposes.
- Maxim Group LLC sole placement agent; registration statement to be filed within 15 trading days of closing, effective within 60.
- Pre-funded warrants carry 9.99% beneficial ownership cap; common warrants 4.99% cap, issuable only after Nasdaq Rule 5635(d) approval.

## SEC filing metadata
- accession: 0001493152-26-044078
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2026-09-24T12:30:16+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000149315226044078/0001493152-26-044078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000149315226044078/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-044078
- JSON: https://secwatch.observer/filing/0001493152-26-044078.json
- Plain text: https://secwatch.observer/filing/0001493152-26-044078.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.